TW:NASDAQTradeweb Markets Inc. Analysis
Data as of 2026-08-10 - not real-time
$102.97
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
At $102.97, Tradeweb Markets Inc. shows no decisive moving-average alignment, leaving the trend neutral. Over a rolling month the price has gained 10.1%. Momentum indicators put RSI at 53.6 (neutral) with MACD reading bullish. Recent trading has carved out support near $94.29 and resistance around $108.75.
The shares look fair, trading on 24.6 times earnings above a sector average of 16.9. The average analyst target implies 20.3% above today's level. Revenue is growing at 9.0% on a 40.7% profit margin. The 0.55% dividend yield looks covered by current payout levels.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 45.8%, a beta of -0.21 and a maximum drawdown of 32.1%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.
The shares look fair, trading on 24.6 times earnings above a sector average of 16.9. The average analyst target implies 20.3% above today's level. Revenue is growing at 9.0% on a 40.7% profit margin. The 0.55% dividend yield looks covered by current payout levels.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 45.8%, a beta of -0.21 and a maximum drawdown of 32.1%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.
Top Market Events
NEW YORK, July 15, 2026--Tradeweb Markets Inc.Electronic trading platform Tradeweb Markets NASDAQ:TW nearly in Q2 CY2026, with sales up 9% year on year to $558.Hosted on MSN17dTradeweb Markets TW earnings expected to grow: Should you buy?
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading below the 200-day average of 108.95
- MACD momentum is positive
- 30-day price change of +10.1%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 24.6 versus sector average of 16.9
- Trading below the 200-day average of 108.95
- Analyst targets imply +20.3% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 24.6 versus sector average of 16.9
- Analyst targets imply +20.3% versus the current price
- Profit margin of 40.7% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth9.00%
Profit Margin40.70%
P/E Ratio24.6
ROE14.47%
ROA12.48%
Debt/Equity2.05
P/B Ratio3.3
Op. Cash Flow$1.2B
Industry P/E16.9
Technical Analysis
TrendNeutral
RSI53.6
Support$94.29
Resistance$108.75
MA 20$101.12
MA 50$99.98
MA 200$108.95
MACDBullish
VolumeIncreasing
Fear & Greed Index93.89
Valuation
Fair Value$80.64
Target Price$123.86
Upside/Downside20.28%
GradeFair
TypeBlend
Dividend Yield0.55%
Risk Assessment
Beta-0.21
Volatility45.77%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.